HealthDay on MSN2d
Risk for Chronic Fatigue Syndrome Higher After COVID-19
The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.
News Medical on MSN2d
COVID-19 dramatically raises the risk of developing ME/CFS
Study highlights a fourfold increase in ME/CFS risk among COVID-19 patients, with 89% of post-COVID ME/CFS cases overlapping ...
News Medical on MSN2d
Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency
Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...
HealthDay on MSN4d
Extended Nirmatrelvir/Ritonavir Beneficial for Some With Long COVID
Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.
Daily Caller on MSN20hOpinion
Government Debars Notorious Fauci Crony, Gain-Of-Function Mastermind Peter Daszak
The U.S. Department of Health and Human Services (HHS) formally debarred Peter Daszak, president of EcoHealth Alliance, a ...
Knowridge5h
How the virus behind COVID-19 can harm your blood vessels and your heart
It started as a respiratory illness – or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that ...
Pharmabiz2d
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...